Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dachengqi Decoction is a classic traditional Chinese herbal formula originally documented in "Discussion of Cold Damage" (220 AD). It consists of four primary herbs: Radix et Rhizoma Rhei (Da Huang), Cortex Magnoliae Officinalis (Hou Pu), Fructus Aurantii Immaturus (Zhi Shi), and Natrii Sulfas (Mang Xiao). The formula functions primarily to purge heat from the stomach and intestines and relieve constipation. It is commonly used to treat intestinal obstruction, acute pancreatitis, and promote gastrointestinal motility recovery after surgery. The formula contains various bioactive compounds including tannins, anthraquinones, sennosides, flavonoids (particularly polymethoxyflavones), and lignans. Pharmacological studies have shown that Dachengqi Decoction exhibits anti-inflammatory effects, promotes gastric secretion, improves disorders of gastric electric rhythm, and enhances gastrointestinal motility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dachengqi Decoction.